The blood levels of non-high density lipoprotein cholesterol were found to have a strong association with the long-term risk for a cardiovascular disease event.
Among patients with mild obstructive sleep apnea, quality of life is improved at 3 months for those receiving continuous positive airway pressure therapy plus standard care compared with standard care alone.
The use of percutaneous coronary intervention and coronary artery bypass grafting for the treatment of left main coronary artery disease of low or intermediate anatomic complexity was found to be associated with comparable rates of a composite of death, stroke, and myocardial infarction at 5 years.
This study described data collected from patients who self-selected to participate in the Cleveland Clinic Epilepsy Center’s virtual follow-up program.
Poor seizure control, lack of breastfeeding education from a neurologist or lactation consultant, are factors contributing to lower breastfeeding rates in women with epilepsy, compared with the general population.
The FDA has approved the supplemental New Drug Application for Tiglutik oral suspension to include administration via percutaneous endoscopic gastrostomy (PEG) tubes for the treatment of amyotrophic lateral sclerosis.
The FDA has approved the first generic versions of Gilenya (fingolimod; Novartis) for the treatment of relapsing forms of multiple sclerosis in adults.
Researchers sought to estimate the risk for recurrent febrile seizures and whether there is an association between recurrent febrile seizures and the development of epilepsy, psychiatric disorders, and death later in life.
